MedPath

Improvement in Glycemic Response After Bariatric Surgery

Recruiting
Conditions
Bariatric Surgery
Registration Number
NCT05325736
Lead Sponsor
Weizmann Institute of Science
Brief Summary

decipher the role of microbiota in glycemic response change after bariatric surgery

Detailed Description

Despite the vast knowledge linking the gut microbiome to metabolism and the glucose response, the relation still remains unclear. hopefully, a deep understanding of the mechanisms underlying metabolic improvement following bariatric surgery will make it possible to identify targets for pharmacological intervention, which will reduce the need for surgery and its risks.

Previous studies have characterized the microbiome after bariatric surgery, but most suffer from methodological limitations.

The current study has the potential to be innovative and make a significant contribution to understanding the mechanisms involved in early metabolic improvement after bariatric surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • candidates of bariatric surgery or cholecystectomy
  • age 18-70
  • male/female
Exclusion Criteria
  • previous bariatric surgery
  • type 1 diabetes
  • antibiotic treatment 3 months prior to the study
  • probiotic treatment 3 months prior to the study
  • chronic disease - gastrointestinal disease, malignancy, psychiatric disorder, endocrinologic disorders
  • any pathologic findings during endoscopy
  • participants who will suffer from a post-operation complication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
microbiota compositionup to 4 years

The microbiota composition will be assessed using the stool samples of the participants.

Glycemic responseup to 4 years

The glycemic response will be measured by taking a blood test (glucose) after 12 hours fast and a second blood test (glucose) after an OGTT(oral glucose tolerance test) of 50 g glucose

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Weizmann Institute of Science

🇮🇱

Reẖovot, Israel

Souraski medical center

🇮🇱

Tel Aviv, Israel

Weizmann Institute of Science
🇮🇱Reẖovot, Israel
Avner Leshem, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.